128 related articles for article (PubMed ID: 21729243)
1. Cost-effectiveness of treating first-episode psychosis: five-year follow-up results from an Italian early intervention programme.
Cocchi A; Mapelli V; Meneghelli A; Preti A
Early Interv Psychiatry; 2011 Aug; 5(3):203-11. PubMed ID: 21729243
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of an early assessment service for young people with early psychosis in Hong Kong.
Wong KK; Chan SK; Lam MM; Hui CL; Hung SF; Tay M; Lee KH; Chen EY
Aust N Z J Psychiatry; 2011 Aug; 45(8):673-80. PubMed ID: 21870925
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
[TBL] [Abstract][Full Text] [Related]
4. Health care resource use associated with integrated psychological treatment.
Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
6. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
[TBL] [Abstract][Full Text] [Related]
7. Early psychosis intervention.
Yap HL
Singapore Med J; 2010 Sep; 51(9):689-93. PubMed ID: 20938607
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study).
Hastrup LH; Kronborg C; Bertelsen M; Jeppesen P; Jorgensen P; Petersen L; Thorup A; Simonsen E; Nordentoft M
Br J Psychiatry; 2013 Jan; 202(1):35-41. PubMed ID: 23174515
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
10. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.
Breitborde NJ; Bell EK; Dawley D; Woolverton C; Ceaser A; Waters AC; Dawson SC; Bismark AW; Polsinelli AJ; Bartolomeo L; Simmons J; Bernstein B; Harrison-Monroe P
BMC Psychiatry; 2015 Oct; 15():266. PubMed ID: 26511605
[TBL] [Abstract][Full Text] [Related]
11. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
13. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
14. Economic impact of services for first-episode psychosis: a decision model approach.
McCrone P; Knapp M; Dhanasiri S
Early Interv Psychiatry; 2009 Nov; 3(4):266-73. PubMed ID: 22642729
[TBL] [Abstract][Full Text] [Related]
15. Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis.
Cocchi A; Meneghelli A; Preti A
Aust N Z J Psychiatry; 2008 Dec; 42(12):1003-12. PubMed ID: 19016088
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
17. The economic impact of early intervention in psychosis services for children and adolescents.
McCrone P; Singh SP; Knapp M; Smith J; Clark M; Shiers D; Tiffin PA
Early Interv Psychiatry; 2013 Nov; 7(4):368-73. PubMed ID: 23343433
[TBL] [Abstract][Full Text] [Related]
18. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
Zámbori J; Szádóczky E; Rózsa S; Füredi J
J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
20. Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness study.
Marmo R; Rotondano G; Rondonotti E; de Franchis R; D'Incà R; Vettorato MG; Costamagna G; Riccioni ME; Spada C; D'Angella R; Milazzo G; Faraone A; Rizzetto M; Barbon V; Occhipinti P; Saettone S; Iaquinto G; Rossini FP;
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):535-42. PubMed ID: 17556898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
